BCLC STAGE C HEPATOCELLULAR CARCINOMA

Clinical trials for BCLC STAGE C HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BCLC STAGE C HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for BCLC STAGE C HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 3 Terminated 1

New drug combo tested as second chance for tough liver cancers

Disease control Terminated

This study tested whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, could help control advanced liver cancer in patients whose cancer had continued to grow despite receiving the standard first-line treatment. The trial involved a small group of 15 adults…

Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA

Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

BCLC STAGE C HEPATOCELLULAR CARCINOMA

Get alerted when new BCLC STAGE C HEPATOCELLULAR CARCINOMA trials appear

New drug combo tested as second chance for tough liver cancers